Literature DB >> 30501565

3D Coculture Models Underline Metastatic Melanoma Cell Sensitivity to Vemurafenib.

Delphine Morales1, Florian Lombart2, Agathe Truchot1, Pauline Maire1,3, Marwa Hussein1, Warda Hamitou1, Pascale Vigneron1, Antoine Galmiche3,4, Catherine Lok2, Muriel Vayssade1.   

Abstract

IMPACT STATEMENT: Three dimensional in vitro cell culture systems better reflect the native structural architecture of tissues and are attractive to investigate cancer cell sensitivity to drugs. We have developed and compared several metastatic melanoma (MM) models cultured as a monolayer (2D) and cocultured on three dimensional (3D) dermal equivalents with fibroblasts to better unravel factors modulating cell sensitivity to vemurafenib, a BRAF inhibitor. The heterotypic 3D melanoma model we have established summarizes paracrine signalization by stromal cells and type I collagen matrix, mimicking the natural microenvironment of cutaneous MM, and allows for the identification of potent sensitive melanoma cells to the drug. This model could be a powerful tool for predicting drug efficiency.

Entities:  

Keywords:  3D human melanoma model; BRAFi efficiency; targeted therapy; tissue engineering; tumor microenvironment

Mesh:

Substances:

Year:  2019        PMID: 30501565     DOI: 10.1089/ten.TEA.2018.0210

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  2 in total

Review 1.  Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors.

Authors:  Vincent Roy; Brice Magne; Maude Vaillancourt-Audet; Mathieu Blais; Stéphane Chabaud; Emil Grammond; Léo Piquet; Julie Fradette; Isabelle Laverdière; Véronique J Moulin; Solange Landreville; Lucie Germain; François A Auger; François Gros-Louis; Stéphane Bolduc
Journal:  Biomed Res Int       Date:  2020-04-13       Impact factor: 3.411

2.  A preclinical model of cutaneous melanoma based on reconstructed human epidermis.

Authors:  Anna Leikeim; Maximiliane Wußmann; Freia F Schmidt; Nuno G B Neto; Franziska Benz; Kendra Tiltmann; Corinna Junger; Michael G Monaghan; Bastian Schilling; Florian K Groeber-Becker
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.